Does treating with anti-PD-1 to improve glomerular health come without a cost? Reply
J Clin Invest
.
2022 Nov 15;132(22):e165287.
doi: 10.1172/JCI165287.
Authors
Stuart J Shankland
1
,
Jeffrey W Pippin
1
,
Oliver Wessely
2
Affiliations
1
Division of Nephrology, University of Washington, Seattle, Washington, USA.
2
Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
PMID:
36136431
PMCID:
PMC9663150
DOI:
10.1172/JCI165287
No abstract available
Keywords:
Aging; Drug therapy.
Publication types
Comment
MeSH terms
B7-H1 Antigen*
Programmed Cell Death 1 Receptor*
Substances
Programmed Cell Death 1 Receptor
B7-H1 Antigen
Grants and funding
R01 DK128204/DK/NIDDK NIH HHS/United States